Summary

Infants with Cow’s Milk Protein Allergy have a more immature immune system and a higher propensity for infections with a higher use of antibiotics.  Infants fed with regular IF with the HMO 2 FL and LNnT had significantly fewer reported infections (bronchitis and LRTI), antibiotic and antipyretics use. The first clinical trials of an extensively hydrolysed formula supplemented with the HMO, 2’FL and LNnT, has confirmed the safety and efficacy in infants with Cow’s Milk Protein Allergy.